Postmenopausal women's hormone levels may predict breast cancer risk

10/30/2013 | U.S. News & World Report

High levels of estrogen, androgen and prolactin were associated with an increased risk of developing invasive breast cancer after menopause, U.S. researchers reported. The findings suggest that adding hormone levels to markers already routinely considered could significantly improve breast cancer risk prediction models, study author Shelley Tworoger said.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA